Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Doxylamine succinate; pyridoxine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for doxylamine succinate; pyridoxine hydrochloride?

Doxylamine succinate; pyridoxine hydrochloride is the generic ingredient in four branded drugs marketed by Actavis Labs Fl Inc, Duchesnay, and Sanofi Aventis Us, and is included in four NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

This ingredient has sixty patent family members in thirty-six countries.

There are thirteen drug master file entries for doxylamine succinate; pyridoxine hydrochloride. One supplier is listed for this compound.

Summary for Generic Name: doxylamine succinate; pyridoxine hydrochloride

Tradenames:4
Patents:3
Applicants:3
NDAs:4
Drug Master File Entries: see list13
Suppliers / Packagers: see list1
Clinical Trials: see list1,047
Drug Prices:see low prices
DailyMed Link:doxylamine succinate; pyridoxine hydrochloride at DailyMed

Pharmacology for Ingredient: doxylamine succinate; pyridoxine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc
DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
doxylamine succinate; pyridoxine hydrochloride
TABLET, DELAYED RELEASE;ORAL205811-001Aug 19, 2016RXNoNo► Subscribe► Subscribe
Duchesnay
DICLEGIS
doxylamine succinate; pyridoxine hydrochloride
TABLET, DELAYED RELEASE;ORAL021876-001Apr 8, 2013RXYesYes7,560,122► SubscribeY ► Subscribe
Sanofi Aventis Us
BENDECTIN
doxylamine succinate; pyridoxine hydrochloride
TABLET, EXTENDED RELEASE;ORAL010598-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Duchesnay
BONJESTA
doxylamine succinate; pyridoxine hydrochloride
TABLET, EXTENDED RELEASE;ORAL209661-001Nov 7, 2016RXYesYes► Subscribe► Subscribe
Duchesnay
DICLEGIS
doxylamine succinate; pyridoxine hydrochloride
TABLET, DELAYED RELEASE;ORAL021876-001Apr 8, 2013RXYesYes6,340,695► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: doxylamine succinate; pyridoxine hydrochloride

Country Document Number Estimated Expiration
Argentina034380► Subscribe
United Kingdom0213990► Subscribe
Ukraine74807► Subscribe
Finland117961► Subscribe
Luxembourg90934► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc